Market News

Centre Asset Management Has Lowered Unitedhealth Group (UNH) Stake By $3.28 Million; PDL Biopharma (PDLI)’s Sentiment Is 0.78

PDL BioPharma, Inc. (NASDAQ:PDLI) Logo

Centre Asset Management Llc decreased Unitedhealth Group Inc (UNH) stake by 20.68% reported in 2018Q1 SEC filing. Centre Asset Management Llc sold 15,320 shares as Unitedhealth Group Inc (UNH)’s stock rose 4.65%. The Centre Asset Management Llc holds 58,760 shares with $12.58 million value, down from 74,080 last quarter. Unitedhealth Group Inc now has $242.66 billion valuation. The stock decreased 0.12% or $0.3 during the last trading session, reaching $252.51. About 937,845 shares traded. UnitedHealth Group Incorporated (NYSE:UNH) has risen 37.57% since June 21, 2017 and is uptrending. It has outperformed by 25.00% the S&P500. Some Historical UNH News: 13/03/2018 – UnitedHealth Names Sir Andrew Witty as Optum CEO Effective July 1; 16/05/2018 – Passport Adds Tahoe Resources, Exits UnitedHealth: 13F; 14/03/2018 – UNITEDHEALTH IS SAID TO DROP OUT OF BIDDING FOR ENVISION HEALTH; 07/05/2018 – INSPERITY – ANNOUNCED EXTENSION OF RELATIONSHIP FOR MEDICAL AND DENTAL COVERAGE WITH UNITEDHEALTHCARE; 02/04/2018 – UnitedHealth Group and Humana are launching a pilot program to study whether blockchain technology can help track provider information; 17/04/2018 – UNITEDHEALTH GROUP INC – INCREASED OUTLOOK FOR 2018 NET EARNINGS TO RANGE OF $11.70 TO $11.95/SHARE AND ADJ NET EARNINGS OF $12.40 TO $12.65 PER SHARE; 28/03/2018 – AMERICAN RENAL ASSOCIATES SAYS ON MARCH 27, U.S. COURT ENTERED ORDER GRANTING THE MOTION TO DISMISS IN PART & DENYING THE MOTION IN PART – SEC FILING; 01/05/2018 – United Health Products Expands Animal Testing for HemoStyp┬« in Support of PMA Application, Human Trials to Follow; 16/05/2018 – United Healthcare Steve Nelson To Keynote Second Annual Medicare Advantage Summit; 04/04/2018 – UnitedHealth Closes Above 50-Day Moving Average: Technicals

PDL Biopharma Inc (PDLI) investors sentiment decreased to 0.78 in Q1 2018. It’s down -0.35, from 1.13 in 2017Q4. The ratio turned negative, as 58 active investment managers increased and opened new holdings, while 74 reduced and sold stock positions in PDL Biopharma Inc. The active investment managers in our database now own: 129.11 million shares, down from 134.59 million shares in 2017Q4. Also, the number of active investment managers holding PDL Biopharma Inc in top ten holdings was flat from 0 to 0 for the same number . Sold All: 18 Reduced: 56 Increased: 38 New Position: 20.

Kestrel Investment Management Corp holds 1.81% of its portfolio in PDL BioPharma, Inc. for 1.63 million shares. Hillsdale Investment Management Inc. owns 337,800 shares or 0.14% of their US portfolio. Moreover, Zebra Capital Management Llc has 0.12% invested in the company for 115,431 shares. The British Columbia – Canada-based Connor Clark & Lunn Investment Management Ltd. has invested 0.09% in the stock. Acadian Asset Management Llc, a Massachusetts-based fund reported 4.75 million shares.

The stock decreased 3.52% or $0.09 during the last trading session, reaching $2.47. About 718,315 shares traded. PDL BioPharma, Inc. (PDLI) has risen 20.09% since June 21, 2017 and is uptrending. It has outperformed by 7.52% the S&P500. Some Historical PDLI News: 09/03/2018 – PDL BioPharma Closes Above 50-Day Moving Average: Technicals; 08/03/2018 – PDL BioPharma 4Q EPS 15c; 08/03/2018 – PDL BIOPHARMA 4Q REV. $68.0M; 09/05/2018 – PDL BioPharma 1Q Rev $38.5M; 21/04/2018 – DJ PDL BioPharma Inc, Inst Holders, 1Q 2018 (PDLI); 08/03/2018 – PDL BioPharma 4Q Net $22.3M; 09/04/2018 – PDL BioPharma Presenting at Conference Tomorrow; 15/05/2018 – PDL BioPharma Presenting at UBS Conference May 22; 09/04/2018 – SEVENSAOI CAPITAL – SEVENSAOI’S LETTER TO BOARD OF PDL BIOPHARMA DETAILS 3 MAIN AREAS OF CONCERN, LIKE POOR CAPITAL ALLOCATION, ACQUISITION PRACTICES; 01/05/2018 – HORIZON OIL SAYS REPORTS THAT PDL 10 CANCELLED ARE FALSE

Analysts await PDL BioPharma, Inc. (NASDAQ:PDLI) to report earnings on August, 2. They expect $0.06 EPS, down 76.92% or $0.20 from last year’s $0.26 per share. PDLI’s profit will be $9.04 million for 10.29 P/E if the $0.06 EPS becomes a reality. After $0.08 actual EPS reported by PDL BioPharma, Inc. for the previous quarter, Wall Street now forecasts -25.00% negative EPS growth.

PDL BioPharma, Inc. acquires and manages companies, products, royalty agreements, and debt facilities in the biotech, pharmaceutical, and medical device industries in the United States, Europe, and internationally. The company has market cap of $372.08 million. The firm operates through two divisions, Income Generating Assets and Product Sales. It has a 3.48 P/E ratio. The Income Generating Assets segment consists of royalties from issued patents covering the humanization of antibodies, including Avastin, Herceptin, Xolair, Lucentis, Perjeta, Kadcyla, and Tysabri; and notes and other long-term receivables, royalty rights, hybrid notes/royalties receivable, and equity investments in healthcare companies.

Investors sentiment is 0.96 in Q1 2018. Its the same as in 2017Q4. It has no change, as 55 investors sold UNH shares while 532 reduced holdings. only 125 funds opened positions while 440 raised stakes. 789.19 million shares or 2.09% less from 806.07 million shares in 2017Q4 were reported. James Invest Research Inc, a Ohio-based fund reported 21,376 shares. Hanseatic Mngmt Services reported 7,323 shares. Cypress Cap Mgmt Limited Liability Corp stated it has 0.12% of its portfolio in UnitedHealth Group Incorporated (NYSE:UNH). 4.46 million are held by Intll Investors. Eastern Bank reported 62,664 shares. Sns Group Ltd Liability Co reported 9,474 shares. Credit Suisse Ag has invested 0.75% of its portfolio in UnitedHealth Group Incorporated (NYSE:UNH). Nbt Financial Bank N A Ny stated it has 0.59% of its portfolio in UnitedHealth Group Incorporated (NYSE:UNH). Santa Barbara Asset Mngmt Lc invested in 3.3% or 1.00 million shares. Saturna Cap invested 0.04% of its portfolio in UnitedHealth Group Incorporated (NYSE:UNH). Cleararc Cap Incorporated has 1.27% invested in UnitedHealth Group Incorporated (NYSE:UNH). Lombard Odier Asset Mngmt (Usa) Corp holds 0.27% or 17,800 shares in its portfolio. Rockland stated it has 1,012 shares. Northside Capital Mgmt Limited Liability Com accumulated 0.37% or 5,298 shares. Rbf Cap Llc invested in 55,000 shares or 1.4% of the stock.

Centre Asset Management Llc increased Cl A stake by 590 shares to 11,100 valued at $11.51 million in 2018Q1. It also upped Viacom Inc (NASDAQ:VIAB) stake by 12,830 shares and now owns 216,630 shares. Microsoft Corp (NASDAQ:MSFT) was raised too.

Among 27 analysts covering UnitedHealth Group (NYSE:UNH), 26 have Buy rating, 0 Sell and 1 Hold. Therefore 96% are positive. UnitedHealth Group had 91 analyst reports since September 2, 2015 according to SRatingsIntel. The stock of UnitedHealth Group Incorporated (NYSE:UNH) has “Overweight” rating given on Wednesday, September 9 by Morgan Stanley. The firm earned “Buy” rating on Monday, June 26 by RBC Capital Markets. On Wednesday, September 2 the stock rating was upgraded by Vetr to “Strong-Buy”. Cantor Fitzgerald maintained UnitedHealth Group Incorporated (NYSE:UNH) on Tuesday, October 17 with “Buy” rating. Mizuho maintained UnitedHealth Group Incorporated (NYSE:UNH) rating on Tuesday, July 18. Mizuho has “Buy” rating and $20000 target. The rating was maintained by Mizuho on Friday, October 6 with “Buy”. The stock has “Outperform” rating by Credit Suisse on Wednesday, December 16. Cantor Fitzgerald maintained the stock with “Buy” rating in Wednesday, December 6 report. The stock of UnitedHealth Group Incorporated (NYSE:UNH) earned “Buy” rating by Credit Suisse on Wednesday, November 29. The stock of UnitedHealth Group Incorporated (NYSE:UNH) earned “Overweight” rating by Morgan Stanley on Wednesday, June 7.

Analysts await UnitedHealth Group Incorporated (NYSE:UNH) to report earnings on July, 17. They expect $3.03 EPS, up 23.17% or $0.57 from last year’s $2.46 per share. UNH’s profit will be $2.91B for 20.83 P/E if the $3.03 EPS becomes a reality. After $3.04 actual EPS reported by UnitedHealth Group Incorporated for the previous quarter, Wall Street now forecasts -0.33% negative EPS growth.

More notable recent UnitedHealth Group Incorporated (NYSE:UNH) news were published by: Businesswire.com which released: “AM Best Upgrades Issuer Credit Ratings of UnitedHealth Group Incorporated and Its UnitedHealthcare Subsidiaries” on June 21, 2018, also Benzinga.com with their article: “10 Biggest Price Target Changes For Thursday” published on June 21, 2018, Fool.com published: “The 6 Stocks on the MFM Team’s Radar This Week” on June 19, 2018. More interesting news about UnitedHealth Group Incorporated (NYSE:UNH) were released by: Seekingalpha.com and their article: “UnitedHealth, Quest Diagnostics unveil strategic partnership” published on May 24, 2018 as well as Seekingalpha.com‘s news article titled: “DJ30 Stocks’ Near Price-Change Prospects, Before Index Loss Of GE” with publication date: June 21, 2018.

Since January 18, 2018, it had 0 buys, and 13 sales for $36.37 million activity. Another trade for 15,000 shares valued at $3.51 million was sold by BURKE RICHARD T. Shares for $5.00M were sold by RENFRO LARRY C on Friday, June 15. $2.38M worth of UnitedHealth Group Incorporated (NYSE:UNH) was sold by HOOPER MICHELE J. Shine Kenneth Irwin sold $47,959 worth of stock or 202 shares. Another trade for 10,000 shares valued at $2.46M was made by BALLARD WILLIAM C JR on Tuesday, January 23. WILENSKY GAIL R also sold $1.40 million worth of UnitedHealth Group Incorporated (NYSE:UNH) shares. Nelson Steven H sold 14,233 shares worth $3.28 million.

UnitedHealth Group Incorporated (NYSE:UNH) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *